Australia Technology News API

{
    "totalArticles": 210822,
    "articles": [
        {
            "id": "5fa0d0e341546fa1c0d3d764f3bda7f5",
            "title": "Sick of Copilot? You Can Finally Uninstall Microsoft's AI, But It's Tricky",
            "description": "Microsoft is coming around to the idea that not everyone loves Copilot, so it's taking small steps to let (some) people uninstall it from their Windows devices.",
            "content": "Microsoft has gone all-in on AI and its Copilot chatbot, so it's not going to encourage you to ditch it. However, the company has acknowledged that its AI enthusiasm has left some Windows 11 users frustrated, and is pledging to focus on features that... [1502 chars]",
            "url": "https://au.pcmag.com/ai/116769/sick-of-copilot-you-can-finally-uninstall-microsofts-ai-but-its-tricky",
            "image": "https://sm.pcmag.com/t/pcmag_au/news/s/sick-of-co/sick-of-copilot-you-can-finally-uninstall-microsofts-ai-but_vs5g.1200.jpg",
            "publishedAt": "2026-03-26T16:05:05Z",
            "lang": "en",
            "source": {
                "id": "1140ebf23013e05d5854a27aeef4d7d3",
                "name": "PCMag Australia",
                "url": "https://au.pcmag.com"
            }
        },
        {
            "id": "24d10a0095b3a704bdb5f1a77bab3720",
            "title": "Research Uncovers Why Some Cancer Therapies Fail",
            "description": "Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they typically work for only 40",
            "content": "Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they typically work for only 40 to 80 percent of the patients who would be expected to respond to them.\nIn a new study, MIT research... [5973 chars]",
            "url": "https://www.miragenews.com/research-uncovers-why-some-cancer-therapies-fail-1645112/",
            "image": "https://news.mit.edu/sites/default/files/images/202603/MIT-Drug-Resistance-01-press.jpg",
            "publishedAt": "2026-03-26T15:08:00Z",
            "lang": "en",
            "source": {
                "id": "0368281c39ba31f7435685e8b620f675",
                "name": "Mirage News",
                "url": "https://www.miragenews.com"
            }
        },
        {
            "id": "94d3236f100540e693670fd64267c87d",
            "title": "Study reveals why some cancer therapies don’t work for all patients",
            "description": "MIT researchers figured out why cancer drugs called tyrosine kinase inhibitors don’t always work as expected: Many of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase is turned off.",
            "content": "Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they typically work for only 40 to 80 percent of the patients who would be expected to respond to them.\nIn a new study, MIT research... [5972 chars]",
            "url": "https://news.mit.edu/2026/study-reveals-why-some-cancer-therapies-dont-work-all-patients-0326",
            "image": "https://news.mit.edu/sites/default/files/images/202603/MIT-Drug-Resistance-01-press.jpg",
            "publishedAt": "2026-03-26T15:00:00Z",
            "lang": "en",
            "source": {
                "id": "e6d0a859abd0707cb2c26ce72630b38b",
                "name": "MIT News",
                "url": "https://news.mit.edu"
            }
        }
    ]
}